Concepedia

Publication | Open Access

Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4-1BBzeta retroviral vector: a unicentre phase I/II clinical trial protocol

40

Citations

69

References

2019

Year

Abstract

Eudra CT 2016-004808-60; NCT03676504; Pre-results.

References

YearCitations

Page 1